<?xml version="1.0" encoding="UTF-8"?>
<p>Molecular assays of respiratory specimens are performed for diagnosis purposes usually at the regional referral laboratories designated by WHO (Kaiser Health News, 
 <xref rid="B95" ref-type="bibr">2020</xref>). For regional testing, the CDC started distributing nCOVID-19 test kits on February 7 (WHO, 
 <xref rid="B193" ref-type="bibr">2020a</xref>). nCOVID-19 test is getting more widely available day by day. For hospitals or institutions where nCOVID-19 test is not available, the only option is the testing by CDC. nCOVID-19 should be tested on an urgent basis for the PUI cases. An individual should be removed from PUI status only if that individual is fully evaluated clinically and has consulted with proper healthcare professionals.
</p>
